Information:
Fel:
ID
33807
Beskrivning
The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01083251
Länk
https://clinicaltrials.gov/show/NCT01083251
Nyckelord
Versioner (1)
- 2018-12-28 2018-12-28 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
28 december 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis B Virus NCT01083251
Eligibility Hepatitis B Virus NCT01083251
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis B Virus NCT01083251
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Hepatitis B surface antigen positive Duration
Item
patients were eligible if they had been hbsag positive for at least 6 months,
boolean
C0149709 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
patients were hbeag positive or negative,
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
C0948827 (UMLS CUI [2])
Alanine aminotransferase increased
Item
patients had increased serum alt levels between 1 and 10 times the upper limit of normal (uln),
boolean
C0151905 (UMLS CUI [1])
Hepatitis B DNA Measurement
Item
patients had serum hbv-dna levels greater than 1.0 x 10e5 copies/ml (2.0 x 10e4 iuml), and
boolean
C3641250 (UMLS CUI [1])
Signs and Symptoms Biopsy of liver | Consistent with Chronic Hepatitis B
Item
patients had findings on a liver biopsy within the preceding 12 months that were consistent with the presence of chronic hepatitis b.
boolean
C0037088 (UMLS CUI [1,1])
C0193388 (UMLS CUI [1,2])
C0332290 (UMLS CUI [2,1])
C0524909 (UMLS CUI [2,2])
C0193388 (UMLS CUI [1,2])
C0332290 (UMLS CUI [2,1])
C0524909 (UMLS CUI [2,2])
Decompensated liver disease
Item
decompensated liver disease,
boolean
C4075847 (UMLS CUI [1])
Antiviral Therapy
Item
antiviral therapy within 6 months before randomization,
boolean
C0280274 (UMLS CUI [1])
Coinfection Viral | HCV coinfection | Hepatitis Delta Virus Coinfection | HIV coinfection
Item
viral co-infections (hepatitis c virus, hepatitis delta virus, or human immunodeficiency virus), or
boolean
C0275524 (UMLS CUI [1,1])
C0521026 (UMLS CUI [1,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4])
C0521026 (UMLS CUI [1,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4])
Neutropenia Pre-existing | Thrombocytopenia Pre-existing
Item
pre-existent neutropenia or thrombocytopenia.
boolean
C0027947 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0040034 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])
C2347662 (UMLS CUI [1,2])
C0040034 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])